not going to interfere with the normal biology of the organism, yet have a very high therapeutic index. Philbert suggested that many of the products that can be created will ultimately not be deployable because early safety testing will show them to be completely unfeasible from a toxicological standpoint.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement